Elise Douard1, Abderrahim Zeribi1, Catherine Schramm1, Petra Tamer1, Mor Absa Loum1, Sabrina Nowak1, Zohra Saci1, Marie-Pier Lord1, Borja Rodríguez-Herreros1, Martineau Jean-Louis1, Clara Moreau1, Eva Loth1, Gunter Schumann1, Zdenka Pausova1, Mayada Elsabbagh1, Laura Almasy1, David C Glahn1, Thomas Bourgeron1, Aurélie Labbe1, Tomas Paus1, Laurent Mottron1, Celia M T Greenwood1, Guillaume Huguet1, Sébastien Jacquemont1. 1. Université de Montréal, Montreal (Douard, Zeribi, Schramm, Tamer, Loum, Nowak, Lord, Moreau, Huguet, Jacquemont); UHC Sainte-Justine Research Center, Montreal (Douard, Zeribi, Schramm, Tamer, Loum, Nowak, Saci, Lord, Rodríguez-Herreros, Jean-Louis, Moreau, Huguet, Jacquemont); Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal (Schramm, Greenwood); Sensory-Motor Laboratory, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland (Rodríguez-Herreros); Department of Forensic and Neurodevelopmental Sciences (Loth) and Center for Population Neuroscience and Stratified Medicine (Schumann), Institute of Psychiatry, Psychology, and Neuroscience, King's College London; Hospital for Sick Children and Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto (Pausova); Departments of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal (Elsabbagh); Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, and Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia (Almasy); Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston (Glahn); Human Genetics and Cognitive Functions, Institut Pasteur, Université de Paris, Paris (Bourgeron); Département de Sciences de la Décision, HEC Montreal, Montreal (Labbe); Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto (Paus); Departments of Psychology and Psychiatry, University of Toronto, Toronto (Paus); Centre de Recherche de CIUSSS-NIM, Montreal (Mottron); Département de Psychiatrie, Université de Montréal, Montreal (Mottron); Department of Epidemiology, Biostatistics, and Occupational Health, Gerald Bronfman Department of Oncology, and Department of Human Genetics, McGill University, Montreal (Greenwood).
Abstract
OBJECTIVE: Deleterious copy number variants (CNVs) are identified in up to 20% of individuals with autism. However, levels of autism risk conferred by most rare CNVs remain unknown. The authors recently developed statistical models to estimate the effect size on IQ of all CNVs, including undocumented ones. In this study, the authors extended this model to autism susceptibility. METHODS: The authors identified CNVs in two autism populations (Simons Simplex Collection and MSSNG) and two unselected populations (IMAGEN and Saguenay Youth Study). Statistical models were used to test nine quantitative variables associated with genes encompassed in CNVs to explain their effects on IQ, autism susceptibility, and behavioral domains. RESULTS: The "probability of being loss-of-function intolerant" (pLI) best explains the effect of CNVs on IQ and autism risk. Deleting 1 point of pLI decreases IQ by 2.6 points in autism and unselected populations. The effect of duplications on IQ is threefold smaller. Autism susceptibility increases when deleting or duplicating any point of pLI. This is true for individuals with high or low IQ and after removing de novo and known recurrent neuropsychiatric CNVs. When CNV effects on IQ are accounted for, autism susceptibility remains mostly unchanged for duplications but decreases for deletions. Model estimates for autism risk overlap with previously published observations. Deletions and duplications differentially affect social communication, behavior, and phonological memory, whereas both equally affect motor skills. CONCLUSIONS: Autism risk conferred by duplications is less influenced by IQ compared with deletions. The model applied in this study, trained on CNVs encompassing >4,500 genes, suggests highly polygenic properties of gene dosage with respect to autism risk and IQ loss. These models will help to interpret CNVs identified in the clinic.
OBJECTIVE: Deleterious copy number variants (CNVs) are identified in up to 20% of individuals with autism. However, levels of autism risk conferred by most rare CNVs remain unknown. The authors recently developed statistical models to estimate the effect size on IQ of all CNVs, including undocumented ones. In this study, the authors extended this model to autism susceptibility. METHODS: The authors identified CNVs in two autism populations (Simons Simplex Collection and MSSNG) and two unselected populations (IMAGEN and Saguenay Youth Study). Statistical models were used to test nine quantitative variables associated with genes encompassed in CNVs to explain their effects on IQ, autism susceptibility, and behavioral domains. RESULTS: The "probability of being loss-of-function intolerant" (pLI) best explains the effect of CNVs on IQ and autism risk. Deleting 1 point of pLI decreases IQ by 2.6 points in autism and unselected populations. The effect of duplications on IQ is threefold smaller. Autism susceptibility increases when deleting or duplicating any point of pLI. This is true for individuals with high or low IQ and after removing de novo and known recurrent neuropsychiatric CNVs. When CNV effects on IQ are accounted for, autism susceptibility remains mostly unchanged for duplications but decreases for deletions. Model estimates for autism risk overlap with previously published observations. Deletions and duplications differentially affect social communication, behavior, and phonological memory, whereas both equally affect motor skills. CONCLUSIONS: Autism risk conferred by duplications is less influenced by IQ compared with deletions. The model applied in this study, trained on CNVs encompassing >4,500 genes, suggests highly polygenic properties of gene dosage with respect to autism risk and IQ loss. These models will help to interpret CNVs identified in the clinic.
Entities:
Keywords:
Autism Spectrum Disorder; Copy Number Variants; IQ
Authors: Sébastien Jacquemont; Bradley P Coe; Micha Hersch; Michael H Duyzend; Niklas Krumm; Sven Bergmann; Jacques S Beckmann; Jill A Rosenfeld; Evan E Eichler Journal: Am J Hum Genet Date: 2014-02-27 Impact factor: 11.025
Authors: Damian Szklarczyk; Andrea Franceschini; Stefan Wyder; Kristoffer Forslund; Davide Heller; Jaime Huerta-Cepas; Milan Simonovic; Alexander Roth; Alberto Santos; Kalliopi P Tsafou; Michael Kuhn; Peer Bork; Lars J Jensen; Christian von Mering Journal: Nucleic Acids Res Date: 2014-10-28 Impact factor: 16.971
Authors: A Vangkilde; J R M Jepsen; H Schmock; C Olesen; S Arnarsdóttir; W F C Baaré; K J Plessen; M Didriksen; H R Siebner; T Werge; L Olsen Journal: J Neurodev Disord Date: 2016-11-16 Impact factor: 4.025
Authors: Debra D'Angelo; Sébastien Lebon; Qixuan Chen; Sandra Martin-Brevet; LeeAnne Green Snyder; Loyse Hippolyte; Ellen Hanson; Anne M Maillard; W Andrew Faucett; Aurélien Macé; Aurélie Pain; Raphael Bernier; Samuel J R A Chawner; Albert David; Joris Andrieux; Elizabeth Aylward; Genevieve Baujat; Ines Caldeira; Philippe Conus; Carrina Ferrari; Francesca Forzano; Marion Gérard; Robin P Goin-Kochel; Ellen Grant; Jill V Hunter; Bertrand Isidor; Aurélia Jacquette; Aia E Jønch; Boris Keren; Didier Lacombe; Cédric Le Caignec; Christa Lese Martin; Katrin Männik; Andres Metspalu; Cyril Mignot; Pratik Mukherjee; Michael J Owen; Marzia Passeggeri; Caroline Rooryck-Thambo; Jill A Rosenfeld; Sarah J Spence; Kyle J Steinman; Jennifer Tjernagel; Mieke Van Haelst; Yiping Shen; Bogdan Draganski; Elliott H Sherr; David H Ledbetter; Marianne B M van den Bree; Jacques S Beckmann; John E Spiro; Alexandre Reymond; Sébastien Jacquemont; Wendy K Chung Journal: JAMA Psychiatry Date: 2016-01 Impact factor: 21.596
Authors: Adaikalavan Ramasamy; Daniah Trabzuni; Sebastian Guelfi; Vibin Varghese; Colin Smith; Robert Walker; Tisham De; Lachlan Coin; Rohan de Silva; Mark R Cookson; Andrew B Singleton; John Hardy; Mina Ryten; Michael E Weale Journal: Nat Neurosci Date: 2014-08-31 Impact factor: 24.884
Authors: Sébastien Jacquemont; Guillaume Huguet; Marieke Klein; Samuel J R A Chawner; Kirsten A Donald; Marianne B M van den Bree; Jonathan Sebat; David H Ledbetter; John N Constantino; Rachel K Earl; Donna M McDonald-McGinn; Therese van Amelsvoort; Ann Swillen; Anne H O'Donnell-Luria; David C Glahn; Laura Almasy; Evan E Eichler; Stephen W Scherer; Elise Robinson; Anne S Bassett; Christa Lese Martin; Brenda Finucane; Jacob A S Vorstman; Carrie E Bearden; Raquel E Gur Journal: Am J Psychiatry Date: 2022-03 Impact factor: 19.242
Authors: Aaron Alexander-Bloch; Guillaume Huguet; Laura M Schultz; Nicholas Huffnagle; Sebastien Jacquemont; Jakob Seidlitz; Zohra Saci; Tyler M Moore; Richard A I Bethlehem; Josephine Mollon; Emma K Knowles; Armin Raznahan; Alison Merikangas; Barbara H Chaiyachati; Harshini Raman; J Eric Schmitt; Ran Barzilay; Monica E Calkins; Russel T Shinohara; Theodore D Satterthwaite; Ruben C Gur; David C Glahn; Laura Almasy; Raquel E Gur; Hakon Hakonarson; Joseph Glessner Journal: JAMA Psychiatry Date: 2022-07-01 Impact factor: 25.911
Authors: Ekaterina A Gibitova; Pavel V Dobrynin; Ekaterina A Pomerantseva; Elizaveta V Musatova; Anna Kostareva; Igor Evsyukov; Sergey Y Rychkov; Olga V Zhukova; Oxana Y Naumova; Elena L Grigorenko Journal: Genes (Basel) Date: 2022-05-20 Impact factor: 4.141
Authors: Scott M Myers; Thomas D Challman; Raphael Bernier; Thomas Bourgeron; Wendy K Chung; John N Constantino; Evan E Eichler; Sebastien Jacquemont; David T Miller; Kevin J Mitchell; Huda Y Zoghbi; Christa Lese Martin; David H Ledbetter Journal: Am J Hum Genet Date: 2020-04-30 Impact factor: 11.025
Authors: Claudia Modenato; Kuldeep Kumar; Bogdan Draganski; Sébastien Jacquemont; Clara Moreau; Sandra Martin-Brevet; Guillaume Huguet; Catherine Schramm; Martineau Jean-Louis; Charles-Olivier Martin; Nadine Younis; Petra Tamer; Elise Douard; Fanny Thébault-Dagher; Valérie Côté; Audrey-Rose Charlebois; Florence Deguire; Anne M Maillard; Borja Rodriguez-Herreros; Aurèlie Pain; Sonia Richetin; Lester Melie-Garcia; Leila Kushan; Ana I Silva; Marianne B M van den Bree; David E J Linden; Michael J Owen; Jeremy Hall; Sarah Lippé; Mallar Chakravarty; Danilo Bzdok; Carrie E Bearden Journal: Transl Psychiatry Date: 2021-07-20 Impact factor: 6.222